Arlow, PhD, examine how enzymatic DNA synthesis and DNA construct design mitigate antibody expression challenges.

Transcriptomics of two prevailing models, cuprizone (CPZ) and lysophosphatidylcholine (LPC), reveal understanding of myelin loss and regeneration.

Study found that EPAC2 levels appear to rise gradually as the brain matures, suggesting it may have particular relevance as a ...

GlucoBrain was established to help researchers understand exactly how diseases like diabetes and dementia work at a deeper, ...

The data shows that immune cells converge at sites of motor neuron loss and TDP-43 pathology with distinct patterns depending ...

CEO David Barrett, JD, noted there has been “a nice uptick” in Q1 in start-up funding compared to the same quarter last year, ...

The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a ...

The CHOP's research team findings support the hypothesis that rare AAV integration can contribute to human oncogenesis, which ...

The new CRISPR platform, called ΨDNA, reprograms Cas12 nucleases to recognize and act on RNA using a DNA-based guide scaffold ...

These “living therapeutics” can sustain themselves in vivo and survive in biological environments including tumors, inflamed ...

When these anchors are attached to cancer drugs, they attach to cell membranes and shrink tumors better than unmodified drug ...

Bristol Myers Squibb (BMS) will partner with Hengrui Pharma to co-develop 13 early-stage programs in oncology, hematology, ...